PL1682542T3 - Nowa krystaliczna postać bezwodna o działaniu antycholinergicznym - Google Patents

Nowa krystaliczna postać bezwodna o działaniu antycholinergicznym

Info

Publication number
PL1682542T3
PL1682542T3 PL04791029T PL04791029T PL1682542T3 PL 1682542 T3 PL1682542 T3 PL 1682542T3 PL 04791029 T PL04791029 T PL 04791029T PL 04791029 T PL04791029 T PL 04791029T PL 1682542 T3 PL1682542 T3 PL 1682542T3
Authority
PL
Poland
Prior art keywords
novel crystalline
anticholinergic effect
crystalline anhydride
anhydride
anticholinergic
Prior art date
Application number
PL04791029T
Other languages
English (en)
Inventor
Waldemar Pfrengle
Peter Sieger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34530662&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1682542(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PL1682542T3 publication Critical patent/PL1682542T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL04791029T 2003-11-03 2004-10-29 Nowa krystaliczna postać bezwodna o działaniu antycholinergicznym PL1682542T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03025077 2003-11-03
PCT/EP2004/012269 WO2005042527A1 (de) 2003-11-03 2004-10-29 Neues kristallines anhydrat mit anticholinerger wirksamkeit
EP04791029A EP1682542B1 (de) 2003-11-03 2004-10-29 Neues kristallines anhydrat mit anticholinerger wirksamkeit

Publications (1)

Publication Number Publication Date
PL1682542T3 true PL1682542T3 (pl) 2010-06-30

Family

ID=34530662

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04791029T PL1682542T3 (pl) 2003-11-03 2004-10-29 Nowa krystaliczna postać bezwodna o działaniu antycholinergicznym

Country Status (33)

Country Link
EP (1) EP1682542B1 (pl)
JP (1) JP4553902B2 (pl)
KR (2) KR101285571B1 (pl)
CN (1) CN100509809C (pl)
AR (1) AR046319A1 (pl)
AT (1) ATE453641T1 (pl)
AU (1) AU2004285684B2 (pl)
BR (1) BRPI0415636A (pl)
CA (1) CA2544352C (pl)
CO (1) CO5690641A2 (pl)
CY (1) CY1110339T1 (pl)
DE (1) DE502004010602D1 (pl)
DK (1) DK1682542T3 (pl)
EA (1) EA008587B1 (pl)
EC (1) ECSP066543A (pl)
ES (1) ES2338563T3 (pl)
HR (1) HRP20100029T1 (pl)
IL (1) IL175126A (pl)
ME (1) ME00349B (pl)
MX (1) MX272045B (pl)
MY (1) MY146628A (pl)
NO (1) NO20062569L (pl)
NZ (1) NZ547581A (pl)
PE (1) PE20050996A1 (pl)
PL (1) PL1682542T3 (pl)
PT (1) PT1682542E (pl)
RS (2) RS51599B (pl)
SI (1) SI1682542T1 (pl)
TW (1) TWI336330B (pl)
UA (1) UA82909C2 (pl)
UY (1) UY28596A1 (pl)
WO (1) WO2005042527A1 (pl)
ZA (1) ZA200602344B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008540367A (ja) * 2005-05-02 2008-11-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規結晶性臭化チオトロピウム
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
RU2453547C2 (ru) * 2005-12-19 2012-06-20 Сикор Инк. Новые формы тиотропия бромида и способы их получения
RS52663B2 (sr) * 2005-12-19 2018-05-31 Sicor Inc Nova kristalna forma tiotropijum bromida i proces njene pripreme
JP2009525950A (ja) * 2006-01-04 2009-07-16 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 中等症持続型喘息の治療におけるチオトロピウム塩の使用
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
CN101032484B (zh) * 2007-04-02 2010-05-26 南京卡文迪许生物工程技术有限公司 一种噻托溴铵胶囊型吸入粉雾剂
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
JP2012507574A (ja) * 2008-11-04 2012-03-29 シプラ・リミテッド 医薬エアロゾル組成物
WO2010052450A1 (en) * 2008-11-04 2010-05-14 Cipla Limited Tiotropium bromide having a low degree of crystallinity
NZ597920A (en) 2009-08-07 2014-05-30 Generics Uk Ltd Anhydrate of tiotropium bromide
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
EP2897955B1 (en) * 2012-09-11 2019-11-06 Bilgic, Mahmut New tiotropium bromide crystalline form
UA115888C2 (uk) 2012-11-05 2018-01-10 Зентіва, К.С. Стабілізація сольватів тіотропію
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
WO2017138896A1 (en) 2016-02-11 2017-08-17 Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti Crystalline form of tiotropium bromide anhydrate
EP4108230A1 (en) 2021-06-24 2022-12-28 Laboratoires SMB New dry powder composition of tiotropium for inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
CN100519558C (zh) * 2000-10-12 2009-07-29 贝林格尔英格海姆法玛两合公司 结晶单水合物、其制备方法及其在制备药物组合中的用途
DE10111843A1 (de) * 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
CZ302786B6 (cs) * 2001-06-22 2011-11-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Krystalický bezvodý tiotropiumbromid, zpusob jeho výroby a jeho použití pro výrobu léciva pro lécbu asthmatu

Also Published As

Publication number Publication date
WO2005042527A1 (de) 2005-05-12
EA008587B1 (ru) 2007-06-29
HK1099752A1 (zh) 2007-08-24
ECSP066543A (es) 2006-10-17
DE502004010602D1 (de) 2010-02-11
ZA200602344B (en) 2007-07-25
IL175126A (en) 2010-11-30
CN100509809C (zh) 2009-07-08
MX272045B (en) 2009-11-23
CN1875019A (zh) 2006-12-06
TWI336330B (en) 2011-01-21
RS20060291A (sr) 2008-06-05
PE20050996A1 (es) 2005-12-20
UA82909C2 (en) 2008-05-26
TW200526652A (en) 2005-08-16
RS51599B (sr) 2011-08-31
JP2007509894A (ja) 2007-04-19
AR046319A1 (es) 2005-11-30
HRP20100029T1 (hr) 2010-02-28
AU2004285684B2 (en) 2011-07-14
BRPI0415636A (pt) 2006-12-12
KR101285571B1 (ko) 2013-07-15
DK1682542T3 (da) 2010-05-10
KR20120036381A (ko) 2012-04-17
PT1682542E (pt) 2010-01-27
MXPA06004940A (es) 2006-07-20
SI1682542T1 (sl) 2010-04-30
ES2338563T3 (es) 2010-05-10
NO20062569L (no) 2006-07-12
NZ547581A (en) 2009-03-31
MEP51708A (en) 2011-02-10
AU2004285684A1 (en) 2005-05-12
JP4553902B2 (ja) 2010-09-29
CO5690641A2 (es) 2006-10-31
MY146628A (en) 2012-09-14
CY1110339T1 (el) 2015-01-14
ME00349B (me) 2011-05-10
KR20060121131A (ko) 2006-11-28
EP1682542A1 (de) 2006-07-26
UY28596A1 (es) 2005-06-30
IL175126A0 (en) 2006-09-05
EA200600853A1 (ru) 2006-10-27
CA2544352C (en) 2013-07-16
KR101313904B1 (ko) 2013-09-30
CA2544352A1 (en) 2005-05-12
ATE453641T1 (de) 2010-01-15
EP1682542B1 (de) 2009-12-30

Similar Documents

Publication Publication Date Title
IL175126A0 (en) Novel crystalline anhydride with anticholinergic effect
IL175702A0 (en) Nanoscale crystalline silicon-powder
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
IL174154A0 (en) Novel glp-1 derivatives
ZA200603879B (en) Substituted indazole-O-glucosides
EP1680131A4 (en) SUBSTITUTED INDOLE-O-GLUCOSIDES
AP1955A (en) Novel crystalline modification of the anhydrate ofboscalid
AU2003297594A8 (en) Crystalline form
GB0611515D0 (en) Novel oxy-nitriles
GB2421742B (en) Structural arrangement
ZA200600430B (en) Substituted spirobenzazepines
GB0314149D0 (en) Novel amorphous forms
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
GB0314397D0 (en) Bat
IL172530A0 (en) Novel imidazopyridine compound ii with therapeutic effect
GB0327906D0 (en) Biocatalyst composition
GB0228533D0 (en) Crystalline form
GB0305215D0 (en) Quilt
IL169772A0 (en) Crystalline modification
GB0306714D0 (en) Crystal structure
GB0306673D0 (en) Thread caddy
GB0205591D0 (en) Multi-use duvet
GB0326682D0 (en) Easy duvet
TW543431U (en) Quilt for infants
SI1641793T1 (sl) Nova imidazopiridinska spojina II s terapevtskim učinkom